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The aim of this study was to characterize by classical biotyping and Multi-Locus variable
number tandem repeats (VNTR) Analysis (MLVA) all Brucella spp. derived from human
cases in Belgium from 1996 to 2015. Final goals were to determine the species and biovar,
to trace-back on genetic grounds the origin of each strain when patient history and risk fac-
tors were missing, and to survey for particular trends at the national level.
Methods
A total of 37 Brucella strains, isolated from 37 patients in Belgium, were analyzed by both
classical biotyping and MLVA, and the genetic patterns compared to those of human strains
isolated worldwide.
Results
Classical biotyping revealed that isolates were mainly Brucella melitensis. Most of them
belonged to biovar 3, the most abundant biovar in the Mediterranean region. MLVA con-
firmed that Brucella melitensis is too diverse in VNTRs to be able to make clusters associ-
ated to each biovar, but it allowed retrieving precious epidemiological information. The
analysis highlighted the imported nature of the strains from all over the world with a domi-
nant part from the Mediterranean countries. Findings of the MLVA11 testing were in line with
the travel history of patients coming from Italy, Turkey, Lebanon and Peru. The analysis was
particularly useful because it suggested the geographical origin of the infection for 12/16
patients for whom no case history was available.
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Conclusion
Classical biotyping and MLVA analysis are not exclusive but remain complementary tools
for Brucella melitensis strain surveillance. MLVA11 is sufficient for Brucella-free countries
such as Belgium to trace the geographical origin of infection, but complete MLVA16 is
needed to search for links with endemic areas.
Introduction
Brucellosis is a bacterial zoonosis of economic and public health impact in many countries,
especially in the Mediterranean area. It is caused by Brucella spp. and affects both domestic
and wild animal species, besides humans. In animals, symptoms comprise abortion, infertility
and reduction of milk production [1]. In humans, brucellosis manifests as a febrile, debilitating
illness that, untreated, might evolve into chronic conditions (hepatomegaly, endocarditis,
spondylitis, orchitis, arthritis, neurobrucellosis. . .) [2]. Currently, twelves species of Brucella
have been identified [3], three causing proved zoonotic and economic threats: B. melitensis, B.
abortus and B. suis which preferentially infect small ruminants, cattle and swine, respectively
[4]. Classically, these species are subdivided in biovars: B. melitensis includes three biovars (1,
2 and 3), B. abortus eight (1, 2, 3, 4, 5, 6, 7 and 9), and B. suis five (1–5) [5][6]. The European
Union has declared Belgium as Officially Free of Brucella melitensis (ObmF) in 1991 (Directive
91/68/EEC), and Officially Free of Bovine Brucellosis (OBF) (Commission Decision 2003/467/
EC) in 2003. Various monitoring programmes, including serologic surveys in sheep and diag-
nosis of cattle abortions, are implemented to help preserve this status. Through these mea-
sures, early detection of B. abortus outbreaks in cows was achieved in 2010 and 2012 [7].
Brucella melitensis has never been isolated from animals in Belgium. However, other Brucella
spp. circulate in the country: wild boars host B. suis biovar 2 [8] and marine mammals strains
have been isolated on animals stranded on the Belgian coastline (unpublished data).
Human brucellosis is a mandatory notifiable disease in Belgium. Despite the Brucella-free
status and the continuous monitoring, human brucellosis cases are reported yearly [9].
Applied case definition for human brucellosis is that recommended by the European Centre
for Disease Prevention and Control [10]. Briefly, a confirmed case will meet both clinical
(fever and one other generic symptoms of brucellosis) and laboratory criteria (isolation of the
strain from clinical specimens and/or presence of Brucella specific antibodies in serum
detected by agglutination tests or ELISA). In case of isolation, the identification of the bacterial
species and its biovar is essential for epidemiological follow-up and control of the disease.
Classical biotyping is the gold standard to investigate phenotypic characteristics [11]; this
method becomes uncertain in case of appearance of mutants within the same species or biovar
or the presence of strains with atypical reactions to microbiological tests [12]. Molecular geno-
typing methods assessing polymorphisms in the omp2A and omp2b genes [13] or by the
sequencing of rpoB for example are helpful to confirm the species and the biovars of Brucella
[14]. It is known that some human cases can emerge in ObmF countries with the source of
contamination retrieved in infected endemic wildlife [15]. In this context, deeper molecular
epidemiological tools become particularly interesting to trace-back the infection to identify the
geographical source. To fulfill the objective of sub-species discrimination between strains, Var-
iable Number Tandem Repeats (VNTR) has been investigated in Multi-Locus VNTR Analysis
(MLVA) by various scientific groups since 2003 [6][16][17]. This method has proved its effi-
cacy to obtain epidemiological information on Brucella strains, access to public databases and
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sharing of information between countries. In this study, MLVA was used to characterize Bel-
gian human isolates collected during the national reference activity from 1996 to 2015.
Methods
Bacterial isolates
A total of 37 Brucella strains were isolated from 37 patients in Belgium between 1996 and
2015. They represent all human Brucella isolates collected during this period in Belgium.
These strains were isolated from blood or cerebrospinal fluid at the first line laboratory or at
the National Reference Centre for Brucellosis, Veterinary and Agrochemical Research Centre
(CODA-CERVA) in Brussels. Brucella melitensis 16M was used as reference strain to calibrate
the VNTR units.
Biotyping
All isolates were identified as Brucella species on the basis of morphology and conventional
microbiological procedures according to the OIE manual [18]: requirement of CO2 and O2 for
growth, urease activity, H2S production, sensitivity to thionin (10 and 20 μg/ml), fuchsin
(20 μg/ml) and saphranin (100 μg/ml) dyes and agglutination with monospecific antiserum for
A and M antigens. Brucella monospecific antisera A and M were obtained from FAO/WHO
Collaborating Centre for Brucellosis Reference and Research at the Veterinary Laboratory
Agency, Weybridge, UK.
DNA preparation, PCR and MLVA genotyping
A loopful of cultured bacterial cells were dissolved in water, heat treated at 99˚C for 15 min
and, after centrifugation, the supernatant was used as DNA template. PCR amplification was
performed in a total volume of 25 μL containing 20 ng of DNA, 1x PCR reaction Buffer (Invi-
trogen), bethain 5M (Sigma), 1U of Taq DNA polymerase rec (Invitrogen), 50 mM of MgCl2,
5 mM of each dNTPs and 10 μM of each MLVA locus flanking primers [6]. The following
PCR program with the thermocycler iCycler BioRad was used: an initial denaturating step at
96˚C during 5 min followed by 30 cycles of 96˚C for 30 sec, 60˚C for 30 sec, 70˚C for 1 min
and a final extension step of 70˚C for 5 min.
Genotyping was performed using a combination of both minisatellites and microsatellites
repeats based on the scheme initially described by Le Fleche et al. [6], and adjusted by Al
Dahouk et al. [17]. The tandem-repeat loci were divided into three groups as previously
described [17]: eight minisatellite loci in panel 1 (bruce06, bruce08, bruce11, bruce12,
bruce42, bruce43, bruce45, and bruce55), three microsatellite loci in panel 2A (bruce18,
bruce19, and bruce21) (altogether MLVA11), and five microsatellite loci in panel 2B (bruce04,
bruce07, bruce09, bruce16, and bruce30) (MLVA16).
For the markers bruce06, bruce11, bruce42, and bruce55 with repeat unit size of 134 bp, 63
bp, 125 bp and 40bp respectively, the PCR fragment size was evaluated by 2% agarose gel elec-
trophoresis. DNA from the reference strain B. melitensis 16 M, for which repeats lengths are
known, was used for standardization. A 100-bp ladder (Invitrogen) was used as molecular size
marker. Ethidium bromide-stained gels were visualized by UV light and photographed with
GeneGenius bio-imaging system (Syngene). For the markers bruce08, bruce12, bruce43,
bruce45, bruce18, bruce19, bruce21, bruce04, bruce07, bruce09, bruce16 and bruce30, the
PCR products length were defined by capillary electrophoresis with the CEQ 8000 Genetic
Analysis System (Beckman Coulter, Indianapolis, IN, USA). The size of each PCR product was
then converted to a corresponding tandem repeat number as described by Le Fleche et al. [6].
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Analysis of MLVA data
All data were analyzed using BioNumerics version 6.6 software (Applied Maths, Belgium).
Clustering analysis was performed using categorical coefficient and the unweighted-pair
group method with arithmetic mean algorithm (UPGMA) as indicated previously [17]. Briefly,
three distinct character data sets with different weight were defined according to the diversity
index of the markers and combined using the composite data set tool provided by Bionu-
merics. The first one corresponded to panel 1 markers. Each marker of this panel got an indi-
vidual weight of 2 (total weight for panel 1: 16). The two others form two groups in the panel
2, 2A and 2B. Panel 2A markers got a weight of 1 (total weight for panel 2A: 3) and panel 2B
markers got a weight of 0,2 (total weight of panel 2B: 1). The MLVA profile of the isolates was
also subjected to a minimum spanning tree (MST) analysis, illustrating the diversity existing
within the clusters based on single locus variations (SLV). Units (and not sizes) of each marker
were considered for the analysis. The Hunter-Gaston Discrimination Index (HGDI) was cal-
culated for each locus by the use of the online tool V-DICE (http://www.hpa-bioinformatics.
org.uk/cgi-bin/DICI/DICI.pl, latest access February 25, 2017).
Results
A total of 37 Brucella strains with an average of roughly two strains annually were isolated in
Belgium during the reference activity between 1996 and 2015. Colony morphology, staining,
growth characteristics, and slide agglutination with monospecific anti-Brucella sera were used
to characterize all isolates (Table 1). These standard bacteriological procedures classified the
bacterium at the species and the biovar levels. Globally, biotyping identified 28 strains as B.
melitensis biovar 3, three strains as B. melitensis biovar 1, three as B. melitensis biovar 2, one as
B. melitensis rough, and two as B. abortus biovar 1. The rough strain could not be typed (strain
16) and two smooth B. melitensis biovar 3 strains showed an atypical susceptibility to dyes and
a delayed agglutination with anti-M serum (strain 32 and 37). Susceptibility to phages was
tested in the latter strains which confirmed the identification of atypical B. melitensis biovar 3
strains.
All isolates were further characterized by MLVA (Table 2). The 16 VNTRs were split into
three panels (1, 2A and 2B) [17] because of the difference in their diversity index. Three
MLVA analyses were run depending on the panels considered (MLVA8 = panel 1,
MLVA11 = panel 1 + panel 2A, MLVA16 = panel 1 + panel 2A + panel 2B). A comparison of
the Belgian isolates with the strains present in the public repository by MLVA8 and MLVA11
[19] allowed the identification of the associated genotypes (Table 2). Fourteen genotypes were
identified with respect to the MLVA8; five were new and received numbering as “184- to 188”.
These genotypes were all single-locus variants of known genotypes. Nineteen genotypes were
identified with MLVA11; eight as new, numbered “361- to 368”, seven as single-locus variants
and one as a two-locus variant.
MLVA11 data were used to draw a minimum spanning tree (MST) of Brucella melitensis
strains comprising the human Belgian isolates and the human strains isolated worldwide [19]
(Fig 1). Three main clusters were derived, corresponding to the origin of the isolates: an East
Mediterranean, a West Mediterranean and an American cluster. Belgian human strains did
not cluster within a homogenous cloud, indicating the diversity and suggesting that these iso-
lates were imported. A more detailed link with the geographical origin of some Belgian isolates
could be established (Fig 1 and Table 3). The strains isolated from patients infected in Italy
clustered separately from the other strains, and demonstrated genotypes described for Italian
strains (genotype 51 for MLVA8 and genotypes 91 and 96 for MLVA11). The strains from
patients with a history of contamination in Turkey had genotypes comparable to those
Bio and molecular typing of human Brucella strains (Belgium)

































































































































































































































































































































































































































































































































































































































































































































































































































































Bio and molecular typing of human Brucella strains (Belgium)











































































































































































































































































































































































































































































































































































































































































































































































Bio and molecular typing of human Brucella strains (Belgium)





























































































































































































































































































































































































































Bio and molecular typing of human Brucella strains (Belgium)










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Bio and molecular typing of human Brucella strains (Belgium)
PLOS ONE | https://doi.org/10.1371/journal.pone.0174756 April 6, 2017 8 / 15
described for Turkish strains in the database (mainly genotypes 42 and 43 for MLVA8 and
genotypes 104, 116 and 125 for MLVA11). The only strain isolated from a patient traveling
from Peru felt within the Americas cluster and showed the same genotype as Peruvian strains
present in the public database. The strain of a patient traveling from Morocco had a genotype
close to an African strain in the database. MLVA8 and 11 results suggested a possible origin of
the infection for 12 out of 16 Belgian strains for which information about the patient or stay
abroad was unknown (Table 3). For example, strains 8, 9, 10, 13, 14, 17, 19, 20, 21 and 32 had
typical genotypes of Turkish strains (42 and 43 for MLVA8 and 116 and 125 for MLVA11),
strain 16 demonstrated the same genotype as Italian strains (51 for MLVA8 and 96 for
MLVA11) and strain 15 had a typical genotype of Chinese strains (45 for MLVA8 and 115 for
MLVA11). Little information can be drawn regarding the Brucella abortus strains isolated in
Belgium. One of them had the same genotypes (28 for MLVA8 and 82 for MLVA11) as hun-
dreds of strains isolated all over the world, mainly from cattle. The other strain had a new
genotype.
The complete MLVA16 was used to generate a dendrogram (S1 Fig) revealing that the 37
Belgian isolates clustered in 33 different genotypes. This analysis confirmed that the isolates
came from multiple geographical origins but did not provide additional epidemiological
information.
In certain contexts, MLVA16 can be used to cluster the strains regarding to the biovars, [6]
[20]. For B. melitensis this seems to be not effective [17] [21]. Despite the use of three levels of
analysis (MLVA8/MLVA11/MLVA16), it was not possible to cluster the Belgian B. melitensis
strains according to their biovar. In some cases the three described biovars (bv1; bv2 and bv3)
were found within the same cluster (S1 Fig).
Fig 1. Minimum spanning tree obtained with MLVA-11 data of Belgian human isolates together with
human strains worldwide (public databases). Each strain is represented by a circle. Large circles regroup
strain with identical genotypes dimensionally proportional to the number of entries. The lines, whose length is
drawn on the basis of the number of mutations (number of variant VNTR), connect the different genotypes.
The numbers aside the lines indicate the number of variant VNTRs. The grey areas connect genotypes with
maximum three-locus variants. The East Mediterranean group is colored in blue, the America group in red, the
West Mediterranean group in green, and the Belgian strains in yellow. Arrows describe origins for some
Belgian isolates.
https://doi.org/10.1371/journal.pone.0174756.g001
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The HDGI for the different MLVA16 loci were calculated and confirmed the high discrimi-
natory power of MLVA (S1 Table).
Discussion
Brucellosis is a worldwide zoonotic disease that affects various domestic and wild animals but
some Brucella species are occasionally able to infect humans, considered as accidental hosts.
The transmission occurs by aerosol, consumption of raw dairy products or direct contact with
contaminated animals. Human brucellosis is characterized by a febrile debilitating disease that
Table 3. MLVA11 predicted geographical origin of the Belgian human Brucella strains.
Strain CODA ID Land of origin by information Predicted land of origin by MLVA 11
1 L3/09 Morocco Morocco
2 L3/10 Turkey Turkey
3 L3/14 Turkey Turkey
4 L3/15 Italy Italy
5 L3/23 ? ?
6 L3/107 Peru Peru
7 L3/129 ? ?
8 L3/130 ? Turkey
9 L3/131 ? Turkey
10 L3/134 ? Turkey
11 L3/135 Libanon Libanon
12 L3/136 Libanon Libanon
13 L3/137 ? Turkey
14 L3/138 ? Turkey
15 L3/139 ? China
16 L3/140 ? Italy
17 L3/141 ? Turkey
18 L3/147 ? ?
19 L3/148 ? Turkey
20 L3/149 ? Turkey
21 L3/150 ? Turkey
22 L3/173 Ecuador Ecuador
23 L3/200 China China
24 L3/201 Turkey Turkey
25 L3/202 Turkey Turkey
26 L3/203 Turkey Turkey
27 L3/204 Turkey Turkey
28 L3/205 Turkey Turkey
29 L3/206 Turkey Turkey
30 L3/251 Spain Spain
31 L3/278 ? ?
32 L3/289 ? Turkey
33 L3/295 Italy Italy
34 L3/296 Italy Italy
35 L3/297 Italy Italy
36 L3/298 Afghanistan Afghanistan
37 L3/311 Turkey Turkey
https://doi.org/10.1371/journal.pone.0174756.t003
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can become a chronic infection accompanied with serious complications if not adequately
treated. The impact of the infection on health, the mode of transmission and the zoonotic
aspect of the disease have driven European countries to impose a compulsory declaration for
each confirmed case to the reference centres. In Belgium, like in other OmbF and OBF coun-
tries, human brucellosis is limited to few cases every year and its incidence is low. The majority
of the human cases diagnosed in Belgium are due to travel in endemic countries and to immi-
grations because of the absence of animal control measures in many parts of the world. Epide-
miological surveillance in Brucella-free countries remains therefore essential. In Belgium,
some Brucella species (B.suis, B. ceti and B. pinnipedialis) reside in wildlife and it was recently
shown that clustered outbreaks in domestic animals have occurred. Brucella species are geneti-
cally close to each other [22] and, despite their host preference, some species are able to cross
the host specificity barrier [23][24]. This zoonotic characteristic inevitably justifies passive sur-
veillance of brucellosis in humans. Classical biotyping is the gold standard for species and bio-
var attribution of the isolates but the information lacks resolution. In some cases, appearance
of mutants that generate genetic diversity is responsible for atypical susceptibility to dyes or
delayed agglutination with anti-Brucella sera and thus hinders an accurate identification of the
species and biovar [12]. Molecular genotyping based on single gene or multilocus sequence
typing to identify locus polymorphisms or other mutations in genes have also been developed
to understand the phylogeny of the genus Brucella and try to address the question of species
and biovars [25][26]. These methods are not exhaustive when sub-typing for epidemiological
trace-back is necessary. Since 2002, when the first complete genomic sequences of Brucella
melitensis and suis [27][28] were released, a number of tools have been developed to differenti-
ate the isolates according to DNA repetitive sequences. A first application of microsatellites
fingerprinting to Brucella strains was made in 2003 [16] and was based on nine VNTRs that
allowed discrimination of some isolates beyond the biovar level [29]. Afterwards, other sets of
VNTR markers with a different speed of evolution were identified that demonstrated higher
discriminatory power [6][30]. The group of Al Dahouk modified the set of VNTR markers of
Le Fleche and showed their ability to cluster Brucella melitensis strains in 3 main geographical
groups. In our study, the complete VNTR panel for Brucella was analyzed in strains isolated
from humans in Belgium from 1996 to 2015 to improve their characterization and evaluate
their origin. When compared with biotyping, we could assess the ability of VNTR in the identi-
fication of the biovars of Brucella.
Previous studies showed that MLVA was able to discriminate biovars of Brucella species
such as B. suis and B. abortus [6]. However, it was also shown that the technique has its limita-
tions with exceptions [31] and that it is not possible to discriminate biovars of the B. melitensis
species [17]. Our study confirmed that the high genetic diversity regarding MLVA in this spe-
cies did not allow clustering it according to the biovars. Therefore, classical biotyping and
MLVA characterization remain complementary tools for Brucella strain surveillance. VNTRs
were interesting to understand the epidemiology of the isolated strains. The study of MLVA11
was effective to establish phylogeographic relations of the Belgian strains with strains present
in public databases. For instance, the single strain belonging to the Americas cluster was iso-
lated in a patient that travelled to Peru. It shared the same genotype as 62 strains coming from
Peru described by various groups [32][33]. Six isolates displayed the exact MLVA11 genotypes
of dozens of strains coming from Italy described previously [6][12][17]. While the Italian ori-
gin for 5 of these Belgian isolates was known, thanks to the databases, it is suspected that the
6th patient also contracted the disease in this country. These 6 strains belonged to the West
Mediterranean cluster. A last isolate belonging to this cluster was a new genotype based on a
single locus variant with Italian strains and was isolated from a patient with a travel history in
Spain. The East Mediterranean cluster contained the majority of the strains isolated in
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Belgium. Nine of them shared the same MLVA11 genotype (genotype 43) with dozens of
strains coming from Turkey as previously described [17] [34]. Few strains with the same
MLVA11 genotype come from Syria and Irak [17]; this genotype was also observed in strains
coming from Lebanon [35]. Seven other strains isolated in Belgium shared the same genotype
with a great panel of strains isolated in China [21] and Turkey [17][34] (genotype 42). Infor-
mation about the genotypes present in countries geographically located between Turkey and
China is missing but this genotype 42 seems to be highly represented in the Middle East [17]
[35] and has already been isolated in countries like Kazakhstan [17][36]. We hypothesize that
this particularly stable genotype [21] is largely spread from Turkey to China and that MLVA11
is not variable enough to distinguish strains from this region of the world. Our hypothesis is
sustained by an MST analysis performed on 446 B. melitensis MLVA15 profiles of strains
belonging to the East Mediterranean group [37]. In this study, part of the Turkish genotypes
clustered with most of the genotypes observed in China and Kazakhstan, suggesting a common
origin between strains from the Asian continent and the East Mediterranean area [37].
When examined with MLVA16 which includes panel 2B composed of five unstable satel-
lites with a high mutation rate, Belgian isolates were found highly diverse; 33 genotypes were
distinguished among the 37 isolated strains. They apparently came from all around the Medi-
terranean region except one strain with a genotype clustering together with strains from Peru.
MLVA16 did not add to the information obtained already by MLVA11 that strains isolated in
Belgium were coming from a large panel of areas in the world. It seems that increasing the
number of markers is particularly useful in case of outbreak investigation in endemic coun-
tries. For highly genetic diverse strains such as in the context of imported cases, MLVA11 is in
general sufficient to trace the geographical origin of infection. Accessibility of MLVA16 infor-
mation in public repositories about human strains isolated in Belgium (and worldwide) could
help endemic countries to better investigate a possible link and the spread with their cases.
Classical biotyping revealed that the human cases in Belgium are mainly Brucella melitensis,
a species never isolated in animals in Belgium. This is in agreement with the fact that B. meli-
tensis is much more common than B.abortus in many countries of Eastern Europe and the
Middle East [38]. More precisely, most of the strains belonged to the biovar 3. This is consis-
tent with the fact that the majority of patients travelled to or originated from Mediterranean
countries and the Middle East where this biovar is predominant [11]. Since 1996 only two
human isolates in Belgium revealed to be B. abortus, both belonging to biovar 1. One of the
two patients was coming from Ecuador. To our knowledge, B. abortus is the only species iso-
lated in humans in this country [39]. We do not have any information about the second patient
but it is worthwhile to note that Brucella abortus biovar 1 was not enzootic in Belgium during
the years 1980–2000. It has only been isolated in the late nineties from cattle imported from
Portugal where this biovar was prevalent. Taken together, this information convincingly indi-
cate that the majority of human brucellosis cases in Belgium is associated with travel to Bru-
cella endemic countries as observed in neighbouring countries [40].
Our study is the first characterization of human Brucella isolates in Belgium. It highlights
the genetic diversity of the strains consistent with the imported nature of the infections and
the use of MLVA as an important tool to improve the understanding of the phylogeography of
Brucella.
Supporting information
S1 Fig. Dendrogram using MLVA16 data. Yellow dots correspond to Belgian strains.
(TIF)
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